Probiotic Dietary Supplement Market Size, Share, Growth, and Industry Analysis, By Type (Powder Stick Pack,Capsule,Tablet,Probiotic Drops), By Application (Pharmacy,Supermarkets,Online Stores,Hospitals and Clinics,Direct Sales), Regional Insights and Forecast to 2035

Probiotic Dietary Supplement Market Overview

The global Probiotic Dietary Supplement Market size is projected to grow from USD 9131.49 million in 2026 to USD 9905.85 million in 2027, reaching USD 18998.64 million by 2035, expanding at a CAGR of 8.48% during the forecast period.

The global Probiotic Dietary Supplement Market surpassed 7.8 billion units sold in 2024, with capsules capturing 35.7 percent of share and tablets dominating 40 percent. Asia-Pacific accounted for 38.6 percent of total consumption, while Europe led with more than 40 percent of global share. Complex probiotic supplements alone reached 2.2 billion units in 2024, highlighting rising preference for multi-strain blends. Pharmacies maintained 33.8 percent of distribution, followed by online stores at around 33 percent. Adults represented 79.5 percent of users, and digestive health remained the leading application with 39.5 percent share.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 58 percent of North American consumers increased use of digestive-health supplements.
• Major Market Restraint: 41 percent of manufacturers report regulatory complexity limiting product expansion.
• Emerging Trends: 30 percent of new launches are lactose-free or high-CFU formulations.
• Regional Leadership: Europe holds over 40 percent of global probiotic dietary supplement share.
• Competitive Landscape: Capsules hold 35.7 percent, tablets and softgels 40 percent of format share.
• Market Segmentation: Adults represent 79.5 percent of demand, digestive health 39.5 percent of applications.
• Recent Development: Complex probiotics reached 2.2 billion units in 2024, with Asia-Pacific holding 39 percent share.

Probiotic Dietary Supplement Market Latest Trends

The Probiotic Dietary Supplement Market Latest Trends are shaped by format dominance, demographic focus, and application expansion. Tablets and softgels captured 40 percent of total formats, while capsules accounted for 35.7 percent, together controlling more than three-quarters of the market. Adults represented 79.5 percent of consumers, with digestive health comprising 39.5 percent of usage. Complex probiotic supplements valued at 2.2 billion units in 2024 illustrate strong interest in multi-strain blends.

Probiotic Dietary Supplement Market Dynamics

DRIVER

"Rising demand for digestive-health supplements"

Adults accounted for 79.5 percent of consumption in 2024, and digestive health applications represented 39.5 percent of total usage. Capsules at 35.7 percent and tablets at 40 percent provide convenience and dosage accuracy, making them the preferred formats. North America and Europe together held over 70 percent of global share, where digestive and immune health dominate consumer purchase motives. Complex supplements worth 2.2 billion units highlighted growing adoption of multi-strain digestive products.

RESTRAINT

"Regulatory complexity and high costs"

Regulatory fragmentation affects 41 percent of manufacturers, slowing new product approvals and cross-border launches. Stability requirements increase production cost, with nearly 30 percent of supply chains reporting storage-related losses in hot climates. R&D in high-CFU or lactose-free products raises development costs, creating barriers for small enterprises.

OPPORTUNITY

"Demand for multi-strain, high-CFU, lactose-free formulations"

Multi-strain probiotic supplements reached 2.2 billion units in 2024. High-CFU products represented over 40 percent of format share. Clean-label and lactose-free launches accounted for 25 percent of new introductions, particularly in Asia-Pacific and North America. Online distribution, now at 33 percent, supports these innovative product categories.

CHALLENGE

"Consumer awareness and education gaps"

Despite strong growth, 30 percent of consumers remain unclear about probiotic strain benefits. Around 25 percent of complaints globally are linked to mislabeling or unclear dosage guidelines. In Middle East & Africa, only 20 percent of practitioners recommend probiotics regularly. Limited awareness continues to hinder adoption in emerging economies.

Probiotic Dietary Supplement Market Segmentation

The Probiotic Dietary Supplement Market is segmented by type—Powder Stick Pack, Capsule, Tablet, Probiotic Drops—and by application—Pharmacy, Supermarkets, Online Stores, Hospitals and Clinics, Direct Sales. Capsules accounted for 35.7 percent, while tablets dominated with 40 percent of share. Powder stick packs represented 10 percent, and drops held under 5 percent. Pharmacies maintained 33.8 percent of distribution, online channels 33 percent, supermarkets 25 percent, hospitals 10 percent, and direct sales 5–10 percent. Adults remained the key demographic with 79.5 percent of demand, while digestive health was the leading application with 39.5 percent of usage.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Powder Stick Pack: Stick packs held around 10 percent of global formats, popular in Asia-Pacific urban markets for on-the-go usage. Doses typically ranged between 10–50 billion CFU, corresponding to 41.1 percent of CFU-based sales. Clean-label blends accounted for 15 percent of stick pack launches.

Powder stick pack segment is projected at USD 3420 million in 2025 with 40.6% share, expected to reach USD 7150 million by 2034, recording a CAGR of 8.7% over the forecast period.

Top 5 Major Dominant Countries in the Powder Stick Pack Segment

• United States: USD 1200 million in 2025 with 35% share, projected at USD 2600 million by 2034 at 9.1% CAGR, driven by strong OTC probiotic supplement penetration in pharmacy channels.
• China: USD 850 million in 2025 with 24.8% share, expected to reach USD 1800 million by 2034 at 8.6% CAGR, fueled by surging online sales and child-focused probiotic formulations.
• Japan: USD 600 million in 2025 with 17.5% share, growing to USD 1280 million by 2034 at 8.8% CAGR, supported by rising senior citizen consumption and convenience packaging demand.
• Germany: USD 430 million in 2025 with 12.6% share, projected at USD 930 million by 2034 at 8.9% CAGR, backed by pharmacy-focused retail channels and increasing gut health supplement uptake.
• India: USD 340 million in 2025 with 10% share, estimated to hit USD 740 million by 2034 at 9.0% CAGR, due to rapid dietary supplement adoption and urban consumer base expansion.

Capsule: Capsules made up 35.7 percent of total formats in 2024, favored for stability and controlled release. High-CFU ranges between 10–50 billion CFU dominated 41.1 percent of demand. Capsules remained popular in North America and Europe, where over 70 percent of global share concentrated.

Capsule format is valued at USD 2500 million in 2025 with 29.7% share, expected to touch USD 5200 million by 2034, posting a CAGR of 8.4% led by strong consumer preference for convenient supplement dosage.

Top 5 Major Dominant Countries in the Capsule Segment

• United States: USD 900 million in 2025 with 36% share, projected at USD 1950 million by 2034 at 8.9% CAGR, bolstered by premium capsule formulations for gut and immune health.
• Germany: USD 500 million in 2025 with 20% share, set to grow to USD 1040 million by 2034 at 8.6% CAGR, supported by medical practitioner endorsements and strong consumer trust in capsules.
• United Kingdom: USD 380 million in 2025 with 15.2% share, forecasted to hit USD 780 million by 2034 at 8.2% CAGR, with higher demand in e-commerce-driven retail platforms.
• China: USD 400 million in 2025 with 16% share, projected at USD 830 million by 2034 at 8.5% CAGR, led by urban middle-class adoption of preventive healthcare supplements.
• France: USD 320 million in 2025 with 12.8% share, expected to reach USD 600 million by 2034 at 7.9% CAGR, influenced by health-conscious consumers and cross-border nutraceutical trade.

BY APPLICATION

Pharmacy: Pharmacies led distribution with 33.8 percent of global share. Capsules and tablets dominated this channel. Multi-strain high-CFU launches represented 30 percent of pharmacy products, reflecting medical trust and pharmacist recommendations.

Pharmacy channel holds USD 3100 million in 2025 with 36.8% share, expected to grow to USD 6350 million by 2034 at 8.4% CAGR.

Top 5 Major Dominant Countries in Pharmacy Application

• United States: USD 1000 million in 2025 with 32.3% share, projected at USD 2050 million by 2034 at 8.6% CAGR, driven by prescription-strength probiotic supplements across nationwide pharmacy chains.
• Germany: USD 600 million in 2025 with 19.3% share, reaching USD 1240 million by 2034 at 8.4% CAGR, supported by physician-backed recommendations and expanding OTC supplement category.
• China: USD 550 million in 2025 with 17.7% share, estimated to hit USD 1100 million by 2034 at 8.3% CAGR, fueled by trust in branded pharmacy-exclusive probiotic formulations.
• France: USD 450 million in 2025 with 14.5% share, forecasted to reach USD 930 million by 2034 at 8.5% CAGR, influenced by national supplement guidelines and strong retail presence.
• India: USD 500 million in 2025 with 16.1% share, projected at USD 1030 million by 2034 at 8.6% CAGR, driven by accessible pharmacies across Tier 2 and Tier 3 cities.

Supermarkets: Supermarkets held 25 percent share, supporting impulse and bulk purchasing. Tablets (40 percent) and capsules (35.7 percent) were the most stocked formats. Lactose-free options accounted for 20 percent of supermarket launches.

Supermarkets account for USD 2100 million in 2025 with 24.9% share, expected to reach USD 4400 million by 2034 at 8.5% CAGR.

Top 5 Major Dominant Countries in Supermarkets Application

• United States: USD 900 million in 2025 with 42.8% share, projected at USD 1880 million by 2034 at 8.6% CAGR, with probiotics prominently displayed in wellness aisles of large chains.
• China: USD 400 million in 2025 with 19% share, expected to hit USD 820 million by 2034 at 8.5% CAGR, benefitting from bulk packaging popularity and high-volume retail distribution.
• United Kingdom: USD 320 million in 2025 with 15.2% share, projected at USD 660 million by 2034 at 8.4% CAGR, reflecting supermarket dominance in dietary supplement retail formats.
• Germany: USD 250 million in 2025 with 11.9% share, reaching USD 510 million by 2034 at 8.6% CAGR, aided by shelf expansions in wellness product categories.
• India: USD 230 million in 2025 with 10.9% share, projected at USD 460 million by 2034 at 8.3% CAGR, driven by organized retail growth in metropolitan regions.

Online Stores: Online sales represented around 33 percent of global distribution. Vegan and clean-label products accounted for 25 percent of online introductions. Personalized capsule subscriptions made up 15 percent of e-commerce offerings.

Online stores segment is worth USD 1700 million in 2025 with 20.2% share, forecasted to reach USD 3580 million by 2034 at 8.6% CAGR.

Top 5 Major Dominant Countries in Online Stores Application

• China: USD 650 million in 2025 with 38.2% share, estimated to hit USD 1380 million by 2034 at 8.9% CAGR, with e-commerce platforms dominating supplement sales.
• United States: USD 500 million in 2025 with 29.4% share, projected at USD 1020 million by 2034 at 8.6% CAGR, reflecting strong subscription-based probiotic delivery services.
• India: USD 220 million in 2025 with 12.9% share, expected at USD 460 million by 2034 at 8.7% CAGR, driven by smartphone penetration and affordable supplement access.
• Japan: USD 200 million in 2025 with 11.8% share, projected at USD 400 million by 2034 at 8.4% CAGR, favored by urban digital-native consumers.
• Germany: USD 130 million in 2025 with 7.6% share, forecasted to hit USD 270 million by 2034 at 8.3% CAGR, aided by cross-border nutraceutical imports.

Hospitals and Clinics: Hospitals and clinics contributed 10 percent of distribution, primarily for probiotic drops in pediatric care and capsules in elderly treatments. Clinical practitioners prescribed probiotics in 20 percent of relevant patient cases.

Hospitals and clinics distribution channel is valued at USD 1000 million in 2025 with 11.9% share, anticipated to reach USD 2100 million by 2034 at 8.5% CAGR.

Top 5 Major Dominant Countries in Hospitals and Clinics Application

• United States: USD 400 million in 2025 with 40% share, projected at USD 850 million by 2034 at 8.7% CAGR, led by clinical probiotic use in digestive treatments.
• Germany: USD 200 million in 2025 with 20% share, set to hit USD 410 million by 2034 at 8.4% CAGR, supported by hospital prescription-driven supplement distribution.
• China: USD 180 million in 2025 with 18% share, estimated at USD 380 million by 2034 at 8.6% CAGR, influenced by digestive care recommendations in pediatric and adult hospitals.
• France: USD 120 million in 2025 with 12% share, projected at USD 250 million by 2034 at 8.5% CAGR, fueled by adoption in specialized gastrointestinal treatments.
• India: USD 100 million in 2025 with 10% share, forecasted at USD 210 million by 2034 at 8.6% CAGR, aided by expanding hospital infrastructure and supplement prescriptions.

Direct Sales: Direct sales networks held 5–10 percent share globally. High-CFU and natural blends represented 20 percent of direct-sale launches. This model thrived in Asia-Pacific and Latin America urban markets.

Direct sales channel stands at USD 617 million in 2025 with 7.3% share, projected to hit USD 1183 million by 2034 at 7.5% CAGR.

Top 5 Major Dominant Countries in Direct Sales Application

• United States: USD 180 million in 2025 with 29% share, expected at USD 350 million by 2034 at 7.6% CAGR, supported by MLM networks and personalized supplement sales.
• China: USD 150 million in 2025 with 24.3% share, projected at USD 310 million by 2034 at 7.9% CAGR, fueled by direct consumer outreach and rising functional health trends.
• Brazil: USD 100 million in 2025 with 16.2% share, reaching USD 190 million by 2034 at 7.1% CAGR, driven by wellness-focused community sales models.
• India: USD 90 million in 2025 with 14.6% share, forecasted at USD 170 million by 2034 at 7.2% CAGR, powered by door-to-door supplement sales in urban households.
• Japan: USD 97 million in 2025 with 15.7% share, projected at USD 163 million by 2034 at 6.1% CAGR, with traditional wellness sales channels sustaining growth.

Probiotic Dietary Supplement Market Regional Outlook

Europe leads with over 40 percent of probiotic dietary supplement consumption, North America follows at 34 percent driven by capsules and tablets, while Asia-Pacific holds 38.6 percent share with strong online penetration and lactose-free launches. Middle East & Africa remains under 10 percent but shows growth in pharmacy-led and shelf-stable formulations. Globally, adults account for 79.5 percent of demand and digestive-health applications dominate with 39.5 percent share, aligning with high-CFU capsules and multi-strain innovations.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America represented 34 percent of global market share. The United States alone reached 6.2 billion units in 2025. Probiotic foods made up 57.45 percent of probiotic product consumption, while dietary supplements leaned heavily on capsules and tablets. Pharmacies captured 35 percent of distribution, supermarkets 25 percent, and online channels around 30 percent. Complex probiotics grew rapidly, reaching 2.2 billion units in value. Drops remained niche, serving pediatric and clinical uses. Despite maturity, 30 percent of consumers lacked clarity on probiotic strains, providing opportunities for targeted education and clinical studies.

North America accounts for USD 3100 million in 2025 with 36.8% share, estimated to reach USD 6400 million by 2034 at 8.4% CAGR, fueled by rising healthcare spending and high supplement adoption rates.

North America - Major Dominant Countries in the “Probiotic Dietary Supplement Market”

• United States: USD 2600 million in 2025 with 83.8% share, projected to USD 5300 million by 2034 at 8.6% CAGR, dominating regional sales through strong e-commerce and pharmacy channels.
• Canada: USD 280 million in 2025 with 9% share, expected at USD 580 million by 2034 at 8.4% CAGR, supported by wellness product expansion and preventive health demand.
• Mexico: USD 120 million in 2025 with 3.9% share, projected at USD 260 million by 2034 at 8.7% CAGR, benefitting from urban supplement penetration and pharmacy expansion.
• Cuba: USD 60 million in 2025 with 1.9% share, estimated to reach USD 120 million by 2034 at 8.1% CAGR, slowly adopting dietary supplements via retail reforms.
• Dominican Republic: USD 40 million in 2025 with 1.4% share, forecasted at USD 80 million by 2034 at 8.0% CAGR, driven by rising healthcare-focused retail chains.

EUROPE

Europe led the market with over 40 percent of global share. Adults accounted for 79.5 percent of consumption, and digestive-health applications dominated 39.5 percent of demand. Tablets and capsules made up more than 75 percent of formats. Pharmacies captured more than 33 percent of distribution, supported by high consumer trust. Online sales accounted for about 25 percent. Complex supplements aligned with clinical trends, reflecting 2.2 billion units sold. Stick packs, at 10 percent, gained traction among younger consumers. Regulatory oversight ensured transparency, but 25 percent of consumers still reported confusion on probiotic benefits.

Europe represents USD 2500 million in 2025 with 29.7% share, projected at USD 5150 million by 2034 at 8.5% CAGR, supported by stringent health standards and high consumer trust in dietary supplements.

Europe - Major Dominant Countries in the “Probiotic Dietary Supplement Market”

• Germany: USD 800 million in 2025 with 32% share, projected at USD 1640 million by 2034 at 8.6% CAGR, leading through pharmacy-driven retail channels.
• United Kingdom: USD 600 million in 2025 with 24% share, expected to hit USD 1240 million by 2034 at 8.5% CAGR, supported by increasing online probiotic supplement adoption.
• France: USD 500 million in 2025 with 20% share, projected at USD 1040 million by 2034 at 8.6% CAGR, reflecting steady growth in hospital and clinical distribution.
• Italy: USD 350 million in 2025 with 14% share, estimated at USD 720 million by 2034 at 8.3% CAGR, supported by personalized supplement adoption.
• Spain: USD 250 million in 2025 with 10% share, reaching USD 510 million by 2034 at 8.4% CAGR, fueled by consumer focus on digestive wellness.

ASIA-PACIFIC

Asia-Pacific held 38.6 percent of global probiotic dietary supplement share in 2024. Urbanization, lactose intolerance, and digital access fueled adoption. Capsules (35.7 percent) and tablets (40 percent) dominated, but stick packs reached 10 percent share, reflecting mobile lifestyles. Pharmacies represented around 20 percent of distribution, supermarkets 25 percent, and online stores 35 percent, highlighting e-commerce growth. Clean-label and lactose-free supplements made up 20 percent of launches. Pediatric drops expanded via hospital distribution, but overall accounted for less than 5 percent of formats. Consumer awareness lagged, with 30 percent unclear on strain benefits, limiting penetration potential.

Asia stands at USD 2200 million in 2025 with 26.1% share, projected to touch USD 4500 million by 2034 at 8.6% CAGR, driven by large population base and rapid e-commerce expansion.

Asia - Major Dominant Countries in the “Probiotic Dietary Supplement Market”

• China: USD 1400 million in 2025 with 63.6% share, estimated at USD 2900 million by 2034 at 8.9% CAGR, leading Asia’s online and pharmacy channels.
• Japan: USD 400 million in 2025 with 18.2% share, forecasted at USD 810 million by 2034 at 8.5% CAGR, driven by aging population needs.
• India: USD 280 million in 2025 with 12.7% share, projected at USD 570 million by 2034 at 8.7% CAGR, influenced by urban supplement demand.
• South Korea: USD 80 million in 2025 with 3.6% share, estimated to hit USD 160 million by 2034 at 8.1% CAGR, reflecting steady uptake in urban centers.
• Indonesia: USD 40 million in 2025 with 1.8% share, forecasted to reach USD 80 million by 2034 at 7.9% CAGR, with rising digestive health awareness.

MIDDLE EAST & AFRICA

Middle East & Africa remained emerging, accounting for under 10 percent of global share. Capsules and tablets dominated, consistent with global shares of 35.7 percent and 40 percent. Pharmacies controlled around 30 percent of distribution, supermarkets 20 percent, and online retail 15–20 percent. Hospitals and clinics used drops and capsules for neonatal and elderly care, representing 10 percent of sales. Lactose-free and shelf-stable products represented 15 percent of new launches. Regulatory complexity restrained growth, affecting 35 percent of manufacturers. Only 20 percent of practitioners recommended probiotics, reflecting lower awareness but high potential in preventive healthcare.

Middle East and Africa contribute USD 617 million in 2025 with 7.3% share, projected to grow to USD 1180 million by 2034 at 7.5% CAGR, supported by urban wellness trends and healthcare system expansion.

Middle East and Africa - Major Dominant Countries in the “Probiotic Dietary Supplement Market”

• Saudi Arabia: USD 200 million in 2025 with 32.4% share, projected at USD 400 million by 2034 at 7.8% CAGR, fueled by premium supplement imports.
• UAE: USD 150 million in 2025 with 24.3% share, estimated at USD 310 million by 2034 at 7.9% CAGR, driven by retail pharmacy expansion.
• South Africa: USD 120 million in 2025 with 19.4% share, projected at USD 230 million by 2034 at 7.2% CAGR, reflecting local supplement manufacturing growth.
• Egypt: USD 90 million in 2025 with 14.6% share, expected at USD 170 million by 2034 at 7.1% CAGR, supported by middle-class adoption.
• Nigeria: USD 57 million in 2025 with 9.2% share, forecasted at USD 110 million by 2034 at 7.5% CAGR, with growing youth health-conscious consumers.

List of Top Probiotic Dietary Supplement Companies

• i-Health
• Probi AB
• BioGaia
• Probiotics International Ltd (Protexin)
• UAS Labs
• Winclove

Top Two by Market Share

• BioGaia: Leading with strong pediatric probiotic portfolio and distribution in over 100 countries.
• Probi AB: Holds significant share with partnerships across Europe and North America, focusing on high-CFU capsules.

Investment Analysis and Opportunities

Investments in the Probiotic Dietary Supplement Market are supported by clear numerical opportunities. Complex supplements valued at 2.2 billion units highlight innovation as a high-margin area. Pharmacies accounted for 33.8 percent of distribution, online stores around 33 percent, and supermarkets 25 percent, creating diverse entry channels. Regional leaders—Europe with over 40 percent share, Asia-Pacific with 38.6 percent, and North America with 34 percent—offered scalable platforms. Clean-label, vegan, and lactose-free products represented 25 percent of new launches, while stick packs held 10 percent share. High-CFU capsules, representing 41.1 percent of CFU sales, showed demand for potency. With adults driving 79.5 percent of consumption and digestive-health applications covering 39.5 percent of demand, targeted investments in clinical-backed digestive supplements are attractive.

New Product Development

Product innovation is reshaping the Probiotic Dietary Supplement Market. Capsules accounted for 35.7 percent and tablets 40 percent of total consumption, but new introductions emphasized multi-strain, high-CFU blends valued at 2.2 billion units in 2024. Clean-label vegan and lactose-free products represented 20–30 percent of launches, particularly in North America and Asia-Pacific. Stick packs captured 10 percent share with convenient, travel-ready packaging. Online-exclusive formats, including personalized capsules and subscription kits, made up 25 percent of launches. Drops designed for infants used lower CFU counts of 1–10 billion, representing 20 percent of pediatric innovations. Tablets with delayed-release coatings and stability enhancements grew in Europe, supported by strong regulation.

Five Recent Developments

• Multi-strain complex probiotics surpassed 2.2 billion units in 2024, highlighting innovation.
• Lactose-free and vegan launches grew to 25 percent of all new products.
• Stick pack formats increased to 10 percent of market share globally.
• Online distribution captured 33 percent share, supporting personalized capsule launches.
• Pediatric probiotic drops expanded to 20 percent of new child-health product releases.

Report Coverage

The Probiotic Dietary Supplement Market Report covers segmentation by type, application, distribution, demographics, and CFU counts. By type, tablets and softgels (40 percent), capsules (35.7 percent), stick packs (10 percent), and drops (<5 percent) define format preferences. Applications include pharmacies at 33.8 percent, online stores at 33 percent, supermarkets at 25 percent, hospitals at 10 percent, and direct sales at 5–10 percent. Adults represent 79.5 percent of consumers, with digestive health applications at 39.5 percent. Regionally, Europe holds more than 40 percent share, Asia-Pacific 38.6 percent, North America 34 percent, and Middle East & Africa under 10 percent. The report profiles companies including BioGaia, Probi AB, and others, noting their strategic presence in capsules, tablets, and pediatric drops.

Probiotic Dietary Supplement Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 9131.49 Million in 2026
Market Size Value By	USD 18998.64 Million by 2035
Growth Rate	CAGR of 8.48% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Powder Stick Pack Capsule Tablet Probiotic Drops By Application : Pharmacy Supermarkets Online Stores Hospitals and Clinics Direct Sales
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample